Chitosan and Its Structural Modifications for siRNA Delivery

Mona Y. Al-Absi ¹ , Anna Eleonora Caprifico ¹ , Gianpiero Calabrese ¹ *

Cited by CrossRef: 8

1- Karayianni M, Sentoukas T, Skandalis A, Pippa N, Pispas S. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives. Pharmaceutics. 2023;15(7):1849 [Crossref]

2- Singh P, Singh M, Singh B, Sharma K, Kumar N, Singh D, Klair H, Mastana S. Implications of siRNA Therapy in Bone Health: Silencing Communicates. Biomedicines. 2024;12(1):90 [Crossref]

3- Antoniou V, Mourelatou E, Galatou E, Avgoustakis K, Hatziantoniou S. Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection. Pharmaceutics. 2024;16(7):868 [Crossref]

4- Redhwan M, M.G. H, Samaddar S, Bafail D, Hard S, Guha S. Chitosan/siRNA nanoparticles targeting PARP-1 attenuate Neuroinflammation and apoptosis in hyperglycemia-induced oxidative stress in Neuro2a cells. International Journal of Biological Macromolecules. 2024;282:136964 [Crossref]

5- Wang Z, Pang S, Liu X, Dong Z, Tian Y, Ashrafizadeh M, Rabiee N, Ertas Y, Mao Y. Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy. International Journal of Biological Macromolecules. 2024;273:132579 [Crossref]

6- Regev A, Benafsha C, Goldbart R, Traitel T, Elkabets M, Kost J. Effect of Degree of Substitution and Molecular Weight on Transfection Efficacy of Starch-Based siRNA Delivery System. Polysaccharides. 2024;5(4):580 [Crossref]